Suppression of growth of mouse neuroblastoma and A-10 adenocarcinoma in newborn mice treated with the ganglionic blocking agent chlorisondamine.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D000831:Animals, Newborn; D002714:Chlorisondamine / Q000494:pharmacology*; D005260:Female; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000209:etiology; D051379:Mice; D008805:Mice, Inbred A; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009447:Neuroblastoma / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D013564:Sympathetic Nervous System / Q000502:physiology*
D002714:Chlorisondamine